Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

GlobalData highlights impact of US tariffs on medical robotics industry

The US government’s imposition of new tariffs in 2025 marks a significant shift in trade policy that has wide-reaching implications across multiple sectors, including healthcare. Among the most affected segments is the medical robotics industry, a high-growth field that blends precision engineering, artificial intelligence (AI), and life-saving applications in surgery and diagnostics. While tariffs are […]
Read more

PureTech’s LYT-100 holds potential to expand treatment options for idiopathic pulmonary fibrosis, says GlobalData

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by scarring of lung tissue, leading to impaired lung function and respiratory symptoms. The emerging therapies aim to address unmet needs in IPF management by targeting specific fibrotic pathways. Therapies such as LYT-100 by PureTech, currently in Phase IIb clinical trials, show promise in […]
Read more

Renewables to account for over half of Brazil’s annual power generation in 2035, forecasts GlobalData

Brazil generates power from a diverse range of sources that include thermal sources (gas, oil, and coal), hydropower, nuclear, and renewable. Hydropower accounts for the majority of the country’s annual power generation. However, overdependence on hydropower has made the country vulnerable to droughts. To overcome the challenge, the country is rapidly developing its renewable power […]
Read more

Top 20 global payment companies’ revenue grows by 9% in 2024 as market sees structural shifts, says GlobalData

In 2024, the global payment ecosystem witnessed structural changes with digital acceleration, consumer behavior shifts, and macroeconomic pressures reshaping the industry landscape. The top 20 publicly listed payment companies by revenue have navigated this landscape with varying degrees of agility, innovation, and strategic execution. The top 20 public payment companies saw their revenues rise by […]
Read more

Airbus A350s order to allow IndiGo to gain strategic share in India’s outbound long-haul market, says GlobalData

India’s largest airline, IndiGo, has taken a decisive step in its international expansion roadmap by exercising its option to place additional orders for 30 Airbus A350-900 aircraft in June 2025, effectively doubling its initial commitment to a wide-body fleet from 30 to 60 aircraft. The move allows IndiGo to claim a strategic share in the […]
Read more

Enterprises need to jump on opportunities presented by global AI sovereignty strategies, says GlobalData

AI is no longer simply a competitive differentiator for enterprises; the technology is increasingly critical to national security and economic empowerment, prompting countries across the globe to implement strategies that support AI sovereignty. While narrowly defined by some as a focus primarily on infrastructure, AI sovereignty should include a broad swath of capabilities that relate […]
Read more

EyePoint’s Duravyu holds potential to become new treatment option for wAMD, says GlobalData

EyePoint Pharmaceuticals’ Duravyu (vorolanib) is in the spotlight following its recent advancements in its Phase III trial. The company recently announced the completion of patient enrollment for LUGANO, its pivotal Phase III clinical trial. The current wet age-related macular degeneration (wAMD) treatment landscape is largely dominated by vascular endothelial growth factor (VEGF) inhibitors. Duravyu is […]
Read more

UAE’s power capacity to reach 79.1GW in 2035, forecasts GlobalData

The United Arab Emirates (UAE) boasts one of the most secure and stable electricity supply systems in the region. Leveraging its substantial natural gas and oil reserves, among the largest globally, the UAE generates sufficient electricity to satisfy domestic consumption. The nation primarily utilizes its gas for power generation and for re-injection into oil fields […]
Read more

CAR-T therapies need to overcome current limitations to unlock promising treatment possibilities for solid tumors, says GlobalData

CAR-Ts are revolutionizing the treatment of blood cancers, such as B-cell acute lymphocytic leukemia. However, their success has not yet extended to the realm of solid tumors, as no CAR-T therapy has advanced beyond Phase II in one of these indications. Overcoming current limitations and expanding the reach of CAR-T therapeutics could unlock promising new […]
Read more

UK biopharma venture financing QoQ doubles to $1.1 billion in Q1 2025, reveals GlobalData

UK biopharmaceutical companies experienced a quarter-on-quarter (QoQ) surge in venture financing, reaching $1.1 billion in the first quarter (Q1) of 2025—twice the amount raised in the fourth quarter (Q4) of 2024 and exceeding all quarterly totals from 2021. This surge highlights investor appetite for breakthrough innovation, but growing dependence on US capital and policy-driven cost […]
Read more

Sibeprenlimab’s priority review highlights potential to differentiate in IgAN space, says GlobalData

Otsuka Pharmaceutical recently announced that the FDA has accepted for review the Biologics License Application (BLA) for sibeprenlimab, which acts as A Proliferation Inducing Ligand (APRIL) inhibitor in development for immunoglobulin A (IgA) nephropathy (IgAN). This followed sibeprenlimab’s 2024 FDA breakthrough designation for the same indication. The BLA was supported by the Phase III VISIONARY […]
Read more
1 … 38 39 40 41 42 … 136